Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.147x

Based on the latest financial reports, Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a cash flow conversion efficiency ratio of 0.147x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.25 Billion ≈ $183.09 Million USD) by net assets (CN¥8.50 Billion ≈ $1.24 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600866 equity financing ratio to measure how much of total assets are equity-financed.

Starlake Bioscience Co Inc Zhaoqing Guangdong - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Starlake Bioscience Co Inc Zhaoqing Guangdong's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Starlake Bioscience Co Inc Zhaoqing Guan cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Starlake Bioscience Co Inc Zhaoqing Guangdong Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Starlake Bioscience Co Inc Zhaoqing Guangdong ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Actions Technology Co Ltd SHG:688049	0.043x
180 Life Sciences Corp NASDAQ:ATNF	-0.037x
Suzhou Shijia Science & Technology Inc SHE:002796	-0.031x
Kuaijishan Shaoxing Rice Wine SHG:601579	-0.022x
Shenzhen Tatfook Tech SHE:300134	-0.004x
Ituran Location and Control Ltd NASDAQ:ITRN	0.143x
Compass Minerals International Inc NYSE:CMP	0.720x
XPLR Infrastructure LP Unit NYSE:XIFR	0.000x

Annual Cash Flow Conversion Efficiency for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)

The table below shows the annual cash flow conversion efficiency of Starlake Bioscience Co Inc Zhaoqing Guangdong from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see 600866 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥8.45 Billion ≈ $1.24 Billion	CN¥1.29 Billion ≈ $189.06 Million	0.153x	-48.80%
2024-12-31	CN¥8.03 Billion ≈ $1.18 Billion	CN¥2.40 Billion ≈ $350.87 Million	0.299x	+12.86%
2023-12-31	CN¥7.66 Billion ≈ $1.12 Billion	CN¥2.03 Billion ≈ $296.48 Million	0.265x	+10.25%
2022-12-31	CN¥6.93 Billion ≈ $1.01 Billion	CN¥1.66 Billion ≈ $243.28 Million	0.240x	+121.16%
2021-12-31	CN¥1.78 Billion ≈ $259.83 Million	CN¥192.63 Million ≈ $28.19 Million	0.108x	-27.57%
2020-12-31	CN¥1.67 Billion ≈ $244.23 Million	CN¥249.99 Million ≈ $36.58 Million	0.150x	+6.82%
2019-12-31	CN¥1.52 Billion ≈ $222.47 Million	CN¥213.17 Million ≈ $31.19 Million	0.140x	+164.58%
2018-12-31	CN¥956.42 Million ≈ $139.95 Million	CN¥50.69 Million ≈ $7.42 Million	0.053x	+20.96%
2017-12-31	CN¥914.14 Million ≈ $133.77 Million	CN¥40.05 Million ≈ $5.86 Million	0.044x	+14.12%
2016-12-31	CN¥1.07 Billion ≈ $156.93 Million	CN¥41.17 Million ≈ $6.02 Million	0.038x	+1365.65%
2015-12-31	CN¥1.05 Billion ≈ $153.37 Million	CN¥2.75 Million ≈ $401.72K	0.003x	+119.01%
2014-12-31	CN¥1.47 Billion ≈ $214.84 Million	CN¥-20.22 Million ≈ $-2.96 Million	-0.014x	+28.32%
2013-12-31	CN¥1.47 Billion ≈ $214.44 Million	CN¥-28.16 Million ≈ $-4.12 Million	-0.019x	+88.62%
2012-12-31	CN¥1.63 Billion ≈ $239.18 Million	CN¥-276.02 Million ≈ $-40.39 Million	-0.169x	-561.92%
2011-12-31	CN¥1.80 Billion ≈ $263.72 Million	CN¥65.88 Million ≈ $9.64 Million	0.037x	-43.78%
2010-12-31	CN¥1.61 Billion ≈ $235.47 Million	CN¥104.63 Million ≈ $15.31 Million	0.065x	-79.05%
2009-12-31	CN¥1.02 Billion ≈ $149.30 Million	CN¥316.73 Million ≈ $46.35 Million	0.310x	+61.84%
2008-12-31	CN¥776.46 Million ≈ $113.62 Million	CN¥148.93 Million ≈ $21.79 Million	0.192x	+72.98%
2007-12-31	CN¥742.02 Million ≈ $108.58 Million	CN¥82.28 Million ≈ $12.04 Million	0.111x	+181.49%
2006-12-31	CN¥892.18 Million ≈ $130.55 Million	CN¥35.14 Million ≈ $5.14 Million	0.039x	-26.41%
2005-12-31	CN¥874.86 Million ≈ $128.02 Million	CN¥46.83 Million ≈ $6.85 Million	0.054x	+64.59%
2004-12-31	CN¥893.38 Million ≈ $130.73 Million	CN¥29.05 Million ≈ $4.25 Million	0.033x	-80.35%
2003-12-31	CN¥904.58 Million ≈ $132.37 Million	CN¥149.70 Million ≈ $21.91 Million	0.165x	-24.57%
2002-12-31	CN¥834.94 Million ≈ $122.18 Million	CN¥183.18 Million ≈ $26.81 Million	0.219x	+172.54%
2001-12-31	CN¥755.58 Million ≈ $110.57 Million	CN¥60.82 Million ≈ $8.90 Million	0.081x	-35.25%
2000-12-31	CN¥751.40 Million ≈ $109.95 Million	CN¥93.41 Million ≈ $13.67 Million	0.124x	+65.11%
1999-12-31	CN¥703.50 Million ≈ $102.94 Million	CN¥52.97 Million ≈ $7.75 Million	0.075x	-52.56%
1998-12-31	CN¥448.25 Million ≈ $65.59 Million	CN¥71.14 Million ≈ $10.41 Million	0.159x	--

About Starlake Bioscience Co Inc Zhaoqing Guangdong

SHG:600866 China Biotechnology

Market Cap

$1.08 Billion

CN¥7.36 Billion CNY

Market Cap Rank

#8596 Global

#2043 in China

Share Price

CN¥4.43

Change (1 day)

-1.34%

52-Week Range

CN¥4.39 - CN¥8.39

All Time High

CN¥9.46